质子泵抑制剂导致肝癌,风险增加80%!(12)

Bosco JLF, Silliman RA, Thwin SS, et al. A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies.

J Clin Epidemiol

. 2010;63:64–74.

Llorente C, Schnabl B. The gut microbiota and liver disease.

Cell Mol Gastroenterol Hepatol

. 2015;1:275–284.

Yadlapati R, Kahrilas PJ. When is proton pump inhibitor use appropriate?

BMC Med

. 2017;15:36.

UK Biobank. About UK Biobank. http://www.ukbiobank.ac.uk/about-biobank-uk/. Accessed February 2, 2018.